Your browser doesn't support javascript.
loading
Association of tea and coffee consumption and biliary tract cancer risk: The Biliary Tract Cancers Pooling Project.
Huang, Yu-Han; Loftfield, Erikka; Argirion, Ilona; Adami, Hans-Olov; Albanes, Demetrius; Chan, Andrew T; Fedirko, Veronika; Fraser, Gary E; Freedman, Neal D; Giles, Graham G; Hartge, Patricia; Katzke, Verena; Knutsen, Synnove F; Lacey, James; Liao, Linda M; Luo, Juhua; Milne, Roger L; O'Brien, Katie M; Peters, Ulrike; Poynter, Jenny N; Purdue, Mark P; Robien, Kim; Sandin, Sven; Sandler, Dale P; Setiawan, Veronica W; Kang, Jae H; Simon, Tracey G; Sinha, Rashmi; VoPham, Trang; Weinstein, Stephanie J; White, Emily; Zhang, Xuehong; Zhu, Bin; McGlynn, Katherine A; Campbell, Peter T; Lee, Mei-Hsuan; Koshiol, Jill.
Afiliação
  • Huang YH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Loftfield E; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Argirion I; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Adami HO; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Albanes D; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Chan AT; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
  • Fedirko V; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Fraser GE; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Freedman ND; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Giles GG; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Hartge P; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Katzke V; School of Public Health, Loma Linda University, Loma Linda, California, USA.
  • Knutsen SF; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Lacey J; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
  • Liao LM; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.
  • Luo J; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Milne RL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • O'Brien KM; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Peters U; School of Public Health, Loma Linda University, Loma Linda, California, USA.
  • Poynter JN; Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, California, USA.
  • Purdue MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • Robien K; Department of Epidemiology and Biostatistics, School of Public Health, Indiana University Bloomington, Bloomington, Indiana, USA.
  • Sandin S; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
  • Sandler DP; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.
  • Setiawan VW; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Kang JH; Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
  • Simon TG; Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Sinha R; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • VoPham T; Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
  • Weinstein SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
  • White E; Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA.
  • Zhang X; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Zhu B; Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
  • McGlynn KA; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Campbell PT; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Lee MH; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Koshiol J; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Hepatology ; 79(6): 1324-1336, 2024 06 01.
Article em En | MEDLINE | ID: mdl-38758104
ABSTRACT
BACKGROUND AND

AIMS:

Tea and coffee are widely consumed beverages worldwide. We evaluated their association with biliary tract cancer (BTC) incidence. APPROACH AND

RESULTS:

We pooled data from 15 studies in the Biliary Tract Cancers Pooling Project to evaluate associations between tea and coffee consumption and biliary tract cancer development. We categorized participants as nondrinkers (0 cup/day), moderate drinkers (>0 and <3 cups/day), and heavy drinkers (≥3 cups/day). We estimated multivariable HRs and 95% CIs using Cox models. During 29,911,744 person-years of follow-up, 851 gallbladder, 588 intrahepatic bile duct, 753 extrahepatic bile duct, and 458 ampulla of Vater cancer cases were diagnosed. Individuals who drank tea showed a statistically significantly lower incidence rate of gallbladder cancer (GBC) relative to tea nondrinkers (HR=0.77; 95% CI, 0.64-0.91), and intrahepatic bile duct cancer (IHBDC) had an inverse association (HR=0.81; 95% CI, 0.66-1.00). However, no associations were observed for extrahepatic bile duct cancer (EHBDC) or ampulla of Vater cancer (AVC). In contrast, coffee consumption was positively associated with GBC, with a higher incidence rate for individuals consuming more coffee (HR<3 cups/day =1.29; 95% CI, 1.01-1.66; HR≥3 cups/day =1.49; 95% CI, 1.11-1.99, Ptrend=0.01) relative to coffee nondrinkers. However, there was no association between coffee consumption and GBC when restricted to coffee drinkers. There was little evidence of associations between coffee consumption and other biliary tract cancers.

CONCLUSIONS:

Tea consumption was associated with a lower incidence of GBC and possibly IHBDC. Further research is warranted to replicate the observed positive association between coffee and GBC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Chá / Neoplasias do Sistema Biliar / Café Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology / Hepatology (Baltim.) / Hepatology (Baltimore) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Chá / Neoplasias do Sistema Biliar / Café Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology / Hepatology (Baltim.) / Hepatology (Baltimore) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos